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Abstract
 
Peripheral T cell diversity is virtually constant in the young, but is invariably reduced in aged
mice and humans. CD8
 
  
 
T cell clonal expansions (TCE) are the most drastic manifestation of,
and possible contributors to, this reduced diversity. We show that the presence of TCE results
in reduced CD8
 
 
 
, but not CD4
 
 
 
, T cell diversity, and in functional inability to mobilize parts
of the CD8
 
  
 
T cell repertoire affected by TCE. In the model of herpes simplex virus (HSV)-1
infection of B6 mice, 
 
 
 
90% of the responding CD8
 
  
 
T cells use V
 
 
 
10 or V
 
 
 
8 and are directed
against a single glycoprotein B (gB
 
498-505
 
) epitope, gB-8p. We found that old animals bearing
CD8
 
  
 
TCE within V
 
 
 
10 or V
 
 
 
8 families failed to mount an effective immune response against
HSV-1, as judged by reduced numbers of peptide-major histocompatibility complex tetramer
 
 
 
CD8 T cells and an absence of antiviral lytic function. Furthermore, V
 
 
 
8 TCE experimentally
introduced into young mice resulted in lower resistance to viral challenge, whereas V
 
 
 
5
 
  
 
TCE
induced in a similar fashion did not impact viral resistance. These results demonstrate that age-
related TCE functionally impair the efficacy of antiviral CD8
 
  
 
T cell immunity in an antigen-
specific manner, strongly suggesting that TCE are not the mere manifestation of, but are also a
contributing factor to, the immunodeficiency of senescence.
Key words: aging • TCR • T cell clonal expansions • repertoire diversity • antiviral immunity
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Introduction
 
Aging of the immune system leads to the common but poorly
understood state of immunodeficiency. Unlike the severe
congenital or acquired immunodeficiencies, aging is not asso-
ciated with a decrease in lymphocyte numbers, but rather
with gradual shifts in lymphocyte responsiveness, population
ratios, and repertoire (1–4). Of these three, the least well un-
derstood is the impact of progressive decrease in lymphocyte
antigen receptor diversity (5–9). Within the peripheral T cell
pool, TCR diversity remains remarkably constant between
birth and adulthood, with nearly invariant representation of
peripheral T cells expressing different TCRV
 
  
 
segments and
highly diverse molecular distribution of TCR CDR3 lengths
(10, 11). In senescence, representation of T cells bearing
different TCRV
 
  
 
becomes randomly uneven, with con-
comitant reduction of CDR3 length diversity. A frequent
and drastic hallmark of age-related TCR diversity reduction
is the appearance of CD8 T cell clonal expansions (TCE),
which in some instances can comprise 
 
 
 
80% of the total
CD8 compartment (6, 7, 9, 12). There are numerous out-
standing questions surrounding the appearance, maintenance,
and the physiological role of TCE: are they a consequence of
repeated antigenic challenges (12, 13), a consequence of cyto-
kine dysregulation (14–17), or semi-transformed cells ran-
domly selected from memory cells? Is their status linked to
their replicative history (and how)? At the present, these
questions are under intense scrutiny.
Perhaps an even more critical question relates to their
impact upon the immune responsiveness of the organism.
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TCE are often stable, persisting in the absence of overt
pathogenic challenge. Individuals bearing TCE, therefore,
exhibit natural loss of T cell repertoire diversity, but the
extent of this loss and the relationship between the pres-
ence of TCE and the immunodeficiency of aging is pres-
ently unclear. To answer this question, we evaluated the
impact of TCE upon the ability of old mice to mount a de
novo immune response and found that TCE are likely to
be one of the contributing factors to the poor immune re-
sponsiveness in the elderly.
 
Materials and Methods
 
Mice.
 
21-mo-old female C57/BL6 (B6) mice were purchased
from the National Institute of Aging (via Charles River Laborato-
ries). Animals were housed under specific pathogen-free condi-
tions at the Oregon Health and Science University or at the Me-
morial Sloan-Kettering Cancer Center, and were used at 22–26
mo of age. All animal studies were approved by the respective In-
stitutional Animal Care and Use Committees, in accordance with
all applicable federal, state, and local regulations. Young (2–4-mo-
old) control female B6 mice were purchased from the same
source. At the conclusion of the experiment, thorough clinical ex-
amination and necropsy were performed on all animals and those
exhibiting signs of poor health or tumors were excluded from the
analysis. There was essentially no difference in absolute numbers
of CD8 T cells between old and young animals, regardless of the
TCE status. Thus, old mice had larger spleens than the young
(86.9 
 
  
 
10
 
6 
 
  
 
10.3 
 
  
 
10
 
6 
 
cells vs. 60.2 
 
  
 
8.4 
 
  
 
10
 
6
 
), but with
lower relative CD8 representation (10.6 
 
  
 
2.9% vs. 15.4 
 
  
 
3.7%),
yielding average absolute numbers of 9.2 
 
  
 
2.5 and 9.3 
 
  
 
2.2 
 
 
 
10
 
6 
 
cells for old and young animals, respectively. As reported pre-
viously (1, 3, 18), numbers of CD4 T cells, and thus CD8/CD4
ratios, were decreased in old animals, regardless of the presence of
TCE (see Table I). For viral-resistance studies, C57BL/6 mice un-
derwent adult thymectomy (ATX) and antibody-mediated deple-
tion at 4 wk of age by vacuum suction, and were rested for 4 mo
before viral challenge. In select experiments, these animals were
reconstituted with cells from OT-1 and 2C mice (references 19
and 20, respectively). The effectiveness of thymectomy was veri-
fied at necropsy and only fully thymectomized animals were in-
cluded in this study.
 
Virus, Peptides, Peptide-MHC (pMHC) Tetramers, and Flow Cy-
tofluorometric Analysis (21).
 
HSV-1 (strain 17; provided by S.
Silverstein, Columbia University, New York, NY, or by J. Mc-
Geoch, University of Glasgow, Glasgow, Scotland) was used
throughout the experiments. Peptides gB-8p (HSV-1 glycopro-
tein B
 
498-505
 
, SSIEFARL) and OVA-8p (OVA
 
257-264
 
, SIINFEKL)
were purchased from Research Genetics. H-2K
 
b 
 
tetramers loaded
with OVA-8p or gB-8p were prepared as described previously
(21). To ensure the comparability of the presented studies, all ex-
periments were performed using the same batch of tetramer. K
 
b
 
/
OVA-8p tetramer was used as a negative control and revealed
 
 
 
0.2% nonspecific staining.
For flow cytofluorometry (FCM), 1–2 
 
  
 
10
 
6 
 
splenocytes were
blocked with Fc block (anti–mouse Fc
 
 
 
RI/III; BD Biosciences)
and incubated for 30 min on ice in the presence of a saturating
dose of K
 
b
 
/HSV-8 tetramer-PE and/or the indicated FITC-con-
jugated V
 
 
 
-specific mAb and anti–CD8
 
 
 
-CyChrome (BD Bio-
sciences). After washing, the samples were analyzed using a
FACScan or FACSCalibur instrument/CELLQuest 3.1 software
(Becton Dickinson). 1–4 
 
  
 
10
 
4 
 
cells/sample were analyzed, with
dead cells excluded by selective gating. Markers were set so as to
delimit the discrete population of cells staining positively for a
given V
 
 
 
. This was possible because of the presence of two dis-
tinguishable populations of positive and negative cells in each
case. Due to the variability in staining intensity by different
 
Table I.
 
Depending on the Degree of Expansion, CD8
 
  
 
TCE Numerically Constrict Other CD8
 
 
 
, but Rarely, If Ever, CD4
 
  
 
T Cell Populations
 
Mouse no. no. CD8
 
 
 
no. CD4
 
 
 
%V
 
 
 
2
 
 
 
%V
 
 
 
9
 
 
 
%V
 
 
 
5
 
 
 
%V
 
 
 
8
 
 
 
%V
 
 
 
10
 
 
 
%V
 
 
 
11
(TCE, %)
 
a
 
(
 
 
 
10
 
6
 
)(
 
 
 
10
 
6
 
) CD8 CD4 CD8 CD4 CD8 CD4 CD8 CD4 CD8 CD4 CD8 CD4
Old control
(
 
n
 
 
 
  
 
7)
10.1 
 
 
 
2.7
13.8 
 
 
 
3.7
5.2 
 
 
 
1.1
4.8 
 
 
 
1.1
3.3 
 
 
 
1.2
2.5 
 
 
 
0.9
14.2 
 
 
 
2.6
2.6 
 
 
 
0.8
20.6 
 
 
 
3.3
20.0 
 
 
 
2.9
5.9 
 
 
 
1.6
5.6 
 
 
 
1.2
6.6 
 
 
 
1.5
4.7 
 
 
 
0.6
6050
(V
 
 
 
10, 41.1%)
11.9 12.2 ND ND ND ND
 
7.4
 
b
 
2.5
 
12.0
 
17.4
 
TCE
 
c
 
4.7
4696
(V
 
 
 
9, 17.3%)
7.8 12.9 ND ND
 
TCE
 
c
 
2.8
 
8.8
 
2.2
 
13.8
 
16.9 ND ND
4824
(V
 
 
 
5, 26.4%)
8.4 9.0
 
3.4
 
5.4 ND ND
 
TCE
 
c
 
1.9
 
15.3
 
20.0 4.4 5.5
6040
(V
 
 
 
5, 86.8%)
9.5 12.8 ND ND
 
0.6
 
3.9
 
TCE
 
c
 
2.7
 
10.2
 
17.3
 
0.4
 
5.4
6560
(V
 
 
 
11, 23.8%)
9.9 13.7 ND ND
 
TCE
 
c
 
5.1
 
10.4
 
2.0
 
16.3
 
17.4 4.5 5.1
Spleen T cells from individual old animals were analyzed by viable cell counting and multiparameter FCM for the expression of indicated TCR
segments, CD4 and CD8. In parallel, the clonal nature (
 
 
 
97% of the family belonged to a single clone) of their expanded T cells was verified by
CDR3 length analysis. Results are representative of 17 control and 19 animals with TCE analyzed in this manner.
 
a
 
Calculated from percentages obtained by FCM and total spleen cell numbers (trypan blue exclusion counting).
 
b
 
Families exhibiting a decrease in representation 
 
 
 
1 SD are outlined in bold.
 
c
 
Indicates the TCRV
 
  makeup of the TCE (percent of total CD8  cells belonging to the TCE is indicated in brackets underneath the animal number). Messaoudi et al. 1349
TCRV -specific mAbs, these markers were not identically posi-
tioned for all TCRV  segments. However, they were identically
positioned for the comparative analysis of each individual TCRV 
segment in all animals (young, old with no TCE, old with “irrel-
evant” TCE, and old with V 8 or V 10 TCE).
Immunization and CTL Analysis. Mice were immunized i.p.
with 106 PFU of HSV-1 virus strain 17, or s.c. with 10  M gB-
8p emulsified in adjuvant as described previously (22). 7 d after
HSV-1 injection, splenocytes were used for direct FCM analysis
by tetramer staining and for in vitro restimulation to generate
CTLs. For CTL generation, splenocytes from primed mice were
cocultured with irradiated (30 Gy), gB-8p–coated (1  g/ml) syn-
geneic spleen cells. Thereafter, CTL lines were maintained in
vitro by weekly restimulations with syngeneic irradiated spleno-
cytes coated with gB-8p in the absence of exogenous growth fac-
tors. CTL activity was determined on day 5 after each restimula-
tion in a standard 51Cr assay using H-2b–expressing EL-4 cells
with or without gB-8p as targets.
CDR3 Length Analysis. The assay on CD8- or CD4-depleted
spleen cells obtained by immunomagnetic sorting or antibody
plus C –mediated depletion as described previously (9, 22).
CDR3 length polymorphism profiles of V  families not contain-
ing TCE exhibited comparable diversity to those shown for the
V 5 family (see Fig. 1, A and B). When single peaks, suggestive
of TCE, were detected, the PCR products were sequenced ex-
actly as detailed previously (9), revealing a single readable se-
quence in each case.
mAb-mediated Depletion of T Cell Subsets. V 8  and V 5  T
cells were depleted by i.p. injection of 100  g F23.1 and MR9.4
mAb, respectively. Control animals received an injection of 19E12
Figure 1. TCE drastically disturb di-
versity of T cells in aging mice. Example
of FCM and CDR3 length analysis of
CD8 T cells in old animals without (A)
or with (B) detectable TCE. Top of
rows A and B show FCM analysis of
splenocytes from individual mice for
the expression of CD8 and indicated
V   after hemisplenectomy (reference
9). Numbers denote percentage of V  
cells within the CD8 subset. Mice
shown in B had no other detectable
TCE. Middle rows in rows A and B
show CDR3 length analysis (reference
9) of those TCR families affected by
TCE in mice from B. Note that every
TCE corresponded to a single CDR3
length, confirmed by sequencing to be
a single clone. On the bottom, TCE do
not affect diversity of other TCRV 
families, as exemplified by V 5 profiles
of all mice analyzed in this figure. The same pattern of polymorphic, gaussian-distributed peaks was seen in all other TCRV  families (not depicted).
(C) Independent regulation of related T cell subsets: TCE affect non-TCE cells within the same TCRV  family, but not the cells outside this family,
even if they are related by primary sequence to TCE cells. The CDR3 profile of young (A) and old mice (B–D) bearing either no (B), V 7 (C), or V 8
(D) TCE are shown. The presence of a TCE in V 8 subset does not affect the CDR3 length polymorphism of V 7 subset or vice versa.CTL Immunity Impairment by Age-related TCE Expansions 1350
( Thy-1.1, isotype control) mAb. All antibodies were obtained
from the mAb Core Facility, Memorial Sloan-Kettering Cancer
Center. To test the level of depletion, splenocytes from an inde-
pendent group of depleted animals were used in a proliferation
assay. Net corrected proliferation was as follows: control mice:
anti-V 8: 26,349    3,425 cpm, anti-CD3: 80,133    6,299;
mice depleted of T cells bearing V 8: anti-V 8: 152   88 cpm,
anti-CD3: 76,842   5,246. Furthermore, the pattern of V  use
in the 5-d MLR using splenocytes from depleted or nondepleted
animals responding against irradiated BALB/c cells revealed a
complete lack of V 8 response in depleted mice, but an other-
wise similar use of the other TCRV  segments. Similar results
were obtained after MR9.4-mediated V 5 depletion. Animals
were challenged with the virus after depletion with or without
prior transfer of TCR transgenic cells to simulate the TCE-like
situation (see below).
Experimental Induction of TCE in Young Animals. V 8 or V 5
T cells were depleted in ATX B6.CD45.1 animals by intraperi-
toneal injection of 100  g F23.1 and MR9.4 mAb, respectively,
1 wk after ATX surgery. Control animals received an injection
of mAb 19E12 (isotype control). Success of depletion ( 96%)
was verified by FCM at 7 and 14 d after injection as well as im-
mediately before T cell transfer. OT-1 and 2C transgenic T cells
were enriched by negative selection of B220  CD11B  cells us-
ing MACS separation (Miltenyi Biotec) in accordance with
manufacturer’s directions. Obtained cells were 65–75% CD8  as
determined by FCM, with most of the remaining cells being
CD4 . 2   107 cells were injected i.v. and engraftment success
was evaluated by FCM 24 h later using either IB2 (clonotypic
antibody specific for 2C TCR) or anti-V 5 (clone MR9.4) and
anti-CD45.2 antibodies. Animals were challenged 2 d after
transfer with 6   107 PFU HSV-1 strain 17, clone syn2 , cloned
in our laboratory by three successive rounds of plaque picking.
Survival was scored on a daily basis. Death occurred between
days 6 and 10, and all animals surviving this period remained dis-
ease free for 100 d at which point the experiment was discontin-
ued. Data is shown as percent survival at the termination of the
experiment, with the statistical significance determined using
Fisher’s exact test.
Calculation of TCR Repertoire Constriction by TCE. The pro-
portional reduction of T cells bearing other TCRV  can be cal-
culated in each mouse using the equation (i), (i) x   y/z, where x
is the reduction factor of a T cell population bearing a given
TCRV , y is the percentage in control mice of a repertoire nor-
mally occupied by all other families except the one harboring a
TCE, and z is the residual percentage of a repertoire not occu-
pied by TCE in the TCE-bearing mouse. Thus, for the animal
Sp3.4, x   79.6%: 29%   2.74. It follows that T cells bearing
V 10 (usually 6.5% of all T cells) will make up 2.37% (6.5:2.74)
of all T cells in mouse Sp3.4 with a V 8 TCE. The accuracy of
this calculation can be verified for individual families using the
equation (ii), (ii) p   q   z/y, where p is the percentage of T
cells bearing a given TCRV  in a TCE-bearing mouse, q is the
percentage of T cells bearing the same TCRV  in control mice,
and z and y are as defined for (i). These equations hold true re-
gardless of the relative representation of T cell populations bear-
ing different TCRV .
Results
Identification and Characterization of TCE. TCE are di-
agnosed by a combination of FCM to detect expansion
(Fig. 1, A and B, top rows) and TCR CDR3 length analy-
sis (Fig. 1, A and B, middle and bottom rows), a PCR-
based technique that determines molecular diversity (or
clonality) of involved T cells. To be considered a TCE, an
expansion should be overrepresented by  3 SDs for that
family, and also have a CDR3 length profile showing a
dominant peak. CDR3 regions are the most polymorphic
parts of the TCR and their diversity is representative of T
cell diversity within a given population. CDR3 length
analysis determines the relative abundance of mRNA en-
coding TCR chains of individual CDR3 lengths, which
usually range between 18–39 nucleotides, corresponding to
6–13 amino acids, in length (11), and thereby measures rel-
ative diversity of T cells within the population that ex-
Table II. No Cross-Regulation between V 7 and V 8 Family Members in the CD8 T Cell Compartment
Mouse % F23.1a % V 8.2/8.3 % V 8.1
Fold reduction
V 8.2/8.3 % V 7
Fold reduction
V 7%  V  5
Fold reduction
V 5
Control 1 23.57 12.23 11.31 NA 5.3 NA 10.1 NA
Control 2 19.6 6.7 12.9 NA 6.7 NA 13.3 NA
Control 3 24.2 7.1 17.13 NA 6.3 NA 14.3 NA
Av control 22.5 8.7 13.8 6.1 12.9
SD control 2.5 3.1 3 0.7 2.4
TCE 1 47.6 1.2 46.4 7.3 4.7 1.3 8 1.6
TCE 2 61.7 1.1 60.6 7.9 4.1 1.5 11.4 1.1
TCE 3 44.5 1.3 43.2 6.7 4.3 1.4 6.46 2
Av TCE 51.3 1.2 50.1 7.3 4.4 1.4 8.6 1.6
SD 9.2 0.1 9.3 0.6 0.4 0.1 2.5 0.4
Splenocytes of indicated animals were analyzed by multiparameter FCM for the expression of CD8 and of indicated TCRV  segments. Results are
expressed as percent of CD9 T cells.
NA, not applicable.
aF23.1 detects all Vb8 family members.Messaoudi et al. 1351
presses the amplified mRNA. In young nonimmunized
mice, CDR3 length analysis of CD8  T cells reveals within
each TCRV  family a diverse pattern of CDR3 length
peaks spaced 3 bp (1 amino acid) apart in a Gaussian distri-
bution around the most frequent length (27–30 nucleotides
or 9–10 amino acids), representative of a diverse T cell rep-
ertoire (11). The same pattern is found in old mice not
containing TCE (Fig. 1 A, V 4, 8, V 10, and V 11
shown in the middle, and Fig. 1, A and B, V 5 profiles on
the bottom). Usually, antigenic challenge induces expan-
sions of a handful of T cell clones, leading to relative or ab-
solute dominance of one (monoclonal response) or a few
(oligoclonal response) peaks in the profile (23, 24). Upon
clearing the antigen, most of the expanded cells die by
apoptosis, restoring the Gaussian CDR3 length profile. In
aged mice and humans, the presence of TCE (defined as
single dominant CDR3 length peaks) disturbs or com-
pletely distorts the polymorphic pattern of CDR3 length
distributions in one or more TCRV  families. Four mice
shown in Fig. 1 B (middle) exhibit such dominant peaks,
each in a different V  family. By densitometry and area in-
tegration calculation, TCE peaks in these and other mice
used in this study (Tables I and III) occupied  97% of their
respective TCRV   populations. Upon sequencing, each
peak was shown to represent a single clone (refer to Mate-
rials and Methods), confirming our previously published (9)
and unpublished data on  300 mice. However, although
these TCE affected the percentages of T cells expressing
other V s (Fig. 1 B and Tables I–III), they did not demon-
strably affect their diversity (V 5 profiles in Fig. 1 B, bot-
tom; other V  profiles are not depicted).
FCM analysis demonstrated that the above TCE are ex-
panded in absolute terms. The percentage of T cells bearing
each TCRV  is virtually constant in young mice, such that in
C57BL/6 (B6) mice examined there was 3.2% V 4 , 20.4%
V 8 , 6.5% V 10 , and 4.3% V 11  CD8 T cells (Tables I–
III, reference 25, and not depicted). Old mice without de-
tectable TCE exhibited similar V  distribution amongst CD8
cells (Fig. 1 A, top row, and Table I). By contrast, FCM pro-
files of the old mice containing a single CDR3 peak in one of
the above families demonstrate that TCE distort T cell ho-
meostasis and can make up  80% of the total of CD8 T cells
(Fig. 1 B, top row, and Tables I and III). As expected from
previous data (1, 3), the total CD8/CD4 ratios increased in
most aging animals (averages of CD8/CD4 ratios in TCE-
and non-TCE–bearing old animals varied between 0.67 and
1.0; Tables I–III and not depicted) compared with young B6
animals (ratio: 0.49   0.05).
Next, we investigated the impact of TCE upon the di-
versity and numerical representation of other TCRV  fam-
ilies of both CD8 and CD4 phenotypes. For example, cer-
tain TCRV  families are closely related to each other and
are more divergent from other families. Such is the case
with the members of the V 8 family (V 8.1, V 8.2, and
V 8.3) and their nearest cousin, V 7 (26) Thus, it was of
interest to examine whether the CD8  TCE in these fami-
lies influence each other more than they would influence
other families. As seen in Fig. 1 C and Table II, we found
no evidence of any cross-influence between V 7 and V 8
families, and a profound cross-influence between the mem-
bers of the V 8 family. For example, a CD8  TCE in
V 8.1, for example, led to a 27% reduction in CD8  V 7
and a 30% reduction in an unrelated family, V 5, but to a
 80% reduction in both V 8.2 and V 8.3 (Table II).
CDR3 length analysis corroborated this finding (Fig. 1 C).
This data strongly suggests that despite a degree of amino
acid sequence similarity between V 7 and V 8 polypep-
tides, T cell subsets bearing them seem to be regulated
largely independently of one another. Moreover, the results
illustrate the age-associated reduction in TCR diversity at
both the TCRV  representation and the CDR3  length
level and suggest that some level of homeostatic regulation
might be specific for TCR structures, including V , as pro-
posed previously in other models (27–29).
As all of the above analysis was performed on CD8  T
cells, it was also of interest to evaluate the impact of TCE
upon the CD4 compartment. Clearly there was no major
reduction of CD4 T cell representation in animals bearing
Table III. Characteristics of the Lymphoid Compartment and of 
TCE in Mice Used in the Immunization Experiment
Mouse
TCE V 
(% of CD8)
CD8/CD4
ratio
% CD8 in
young mice (range)
Sp3.4 V 8 (71) NT 20.4 (16–23)
Sp2.2 V 8 (40) NT 20.4 (16–23)
Sp1.5 V 8 (45) NT 20.4 (16–23)
9216 V 8 (78) 1.3 20.4 (16–23)
8197 V 8 (59) 0.6 20.4 (16–23)
8624 V 10 (46) 0.5 6.5 (5–9)
8615 V 10 (42) 1.0 6.5 (5–9)
899 V 10 (36) 1.2 6.5 (5–9)
0.9   0.3
404 V 4 (28) 1.4 3.2 (2–4)
409 V 5 (74) 1.2 12.9 (11–15)
6213 V 5 (71) 0.9 12.9 (11–15)
944 V 7 (45) 0.6 4.7 (2–5)
Sp1.4 V 11 (46) NT 4.3 (3–5)
Sp1.1 V 11 (29) NT 4.3 (3–5)
6198 V 13 (18) 0.5 3.1 (2–4)
0.9   0.4
Summary of old B6 mice with TCE used in the immunization study
(results of which are shown in Table IV and Fig. 4). All old mice used
were 22–25 mo old at the time of functional testing, and were typed for
the presence of TCE (as in Fig. 1) after hemisplenectomy (reference 9).
After surgery, all mice were rested for at least 4 wk before immunization.
Young mice and old mice without TCE (results from five animals/
experiment shown in Fig. 4, A and B, and Table III, representative of 15
in total) were 2–3 and 22–26 mo old, respectively, and were treated
exactly as the old counterparts. Overall, CD8/CD4 ratios were
calculated for individual mice and also for groups of mice with TCE in
V 8, V 10, and in other families (expressed as mean   SD).
NT, not tested.CTL Immunity Impairment by Age-related TCE Expansions 1352
TCE compared with non-TCE controls (Table I), and the
only effect, common to both groups, was the aforemen-
tioned increase in CD8/CD4 ratios, characteristic for the
aging process and possibly related to differential prolifera-
tive characteristics of CD8 and CD4 T cells (30). The
question was whether the CD4 T cells bearing the same
V  family as the TCE would be influenced by the TCE.
Results shown in Table I and Fig. 2 unequivocally show
that there was no specific influence. Thus, in TCE-bearing
animals, all of the CD8  V  families were reduced in rep-
resentation, most of them to a similar extent, and that ex-
tent was proportional to the size of the TCE. For example,
the largest TCE analyzed in this manner, from the mouse
6040, increased more than sevenfold in representation (Fig.
2). This was followed by reduction in absolute numbers
(Fig. 2) and relative representation (Table I) of other CD8 
V  families. By contrast, not a single CD4  T cell family
was affected more than its standard deviation, consistent
with the fact that the ratio of CD8/CD4 cells, even in this
drastic case, was not skewed more than in age-matched
controls without TCE (Fig. 2 and Table I). Moreover, di-
versity of CD4  T cells bearing the same TCRV  family as
the TCE was also largely unperturbed by TCE (Fig. 3). In
animals with less pronounced TCE, CD4  T cells re-
mained unperturbed and the extent of constriction of other
CD8  families was less than in animals with large TCE.
Therefore, the regulation of TCE and TCR family ho-
meostasis is separate for CD8 and CD4 subsets, consistent
with other results indicating that the two represent sepa-
rately regulated compartments (31–35).
The Impact of TCE on Antigen-specific Responses. Next,
we showed that such large TCE impaired the ability of ag-
ing mice to mount a productive immune response against
new antigenic challenge. To that effect, we used HSV-1,
which in B6 mice elicits a vigorous CTL response. This re-
sponse is almost entirely ( 95% of CTL activity) directed
against the immunodominant epitope gB-8p (gB495–502,
SSIEFARL; reference 36). gB-8p–specific CTLs predomi-
nantly use V 10 ( 50–70%) and V 8 ( 20–25%) TCRs
(37). To understand how the presence and the V  pheno-
type of TCE may impact the response to HSV-1 in aged
mice, we performed extensive FCM screening of unimmu-
nized old mice. Experimental animals (Table III) were ac-
crued into four groups: (a) mice with TCE of CD8 V 8
and V 10 phenotypes (i.e., TCE affecting the T cell sub-
sets from which the bulk of anti–gB-8p CTLs are re-
cruited); (b) old mice with TCE bearing V   segments
other than V 8 and V 10, which are not typically mobi-
lized in response to HSV-1 (such as V 5, V 11, and V 7);
Figure 2. CD8  TCE preferentially impact cell numbers of other
CD8 , but not of CD4 , cells. An illustrative example of the impact of a
large CD8  TCE (V 5, making up 86.8% of all CD8  T cells) on other T
cell families in mouse number 6040. Data are expressed as fold increase or
decrease of absolute numbers of CD8  or CD4  T cells bearing different
TCRV  segments (other data for this and other mice, including percentage
values, are shown in Table I). Note that even this large TCE shows little
impact upon total CD4 counts (Table I) and that it exhibits most of its effects
upon other CD8  T cells, whereas scarcely affecting even those CD4  T
cells bearing the same TCR family (V 5).
Figure 3. CD8  TCE do not reduce diversity of CD4  cells belonging to the same V  family. CDR3 length analysis was performed on CD8-enriched
( 88% CD8 ,  1% CD4 ) and CD4-enriched ( 87% CD4 ,  1% CD8 ) cells from animals carrying TCE. Only the polymorphism of the family to
which the TCE belongs is shown; however, no skewing was observed in any other CD8 or CD4 family. Representative examples from five individual
mice (out of  20 analyzed) are shown.Messaoudi et al. 1353
(c) old mice with no detectable CD8 TCE; and (d) young
mice with no TCE.
In three independent experiments summarized in Fig. 4
and Table IV, these mice were immunized with HSV-1. All
young mice mounted a vigorous CTL response to HSV-1,
as judged by the percent of cells stained ex vivo with gB-8p:
Kb tetramers (7.1   0.8% of the total CD8  T cells; Fig. 4
A) and by cytolytic activity after 5 d of in vitro restimulation
with gB-8p (Fig. 4 B). Both old mice without manifest
TCE and those with TCE not affecting V 8 or V 10 sub-
sets mounted an anti–gB-8p CTL response. As expected,
the response of aged mice was less vigorous than that of
young counterparts, with a  25% reduction in the gB-8p:
Kb  CD8 T cells ex vivo (5.3   0.9% CD8  cells scoring as
tetramer ; Fig. 4 A) and an almost 30-fold reduction in
CTL activity (Fig. 4 B) upon one in vitro restimulation, as
judged by the CTL effector/target ratios required to pro-
duce comparable levels of lysis. This indicated that the pres-
ence of clonally expanded T cells in analyzed mice did not
lead to generalized immunosuppression. However, the pres-
ence of a TCE among either the V 10  or V 8  cells be-
fore immunization further reduced the numbers of ex vivo–
detectable antigen-specific CD8 cells (by  60% to 2.2  
0.6%; Fig. 4 A), and completely prevented the development
of a detectable virus-specific CTL response after one in
vitro restimulation in all animals tested (anti–gB-8p re-
sponse; Fig. 4 B and Table IV; anti–HSV-1 response, spe-
cific lysis  1% at any effector/target ratio tested).
Only upon three consecutive in vitro restimulations did
CTL activity become detectable in one half of the cultures.
Even then the efficacy of lysis was far inferior (only  40%
of the control) to that observed in old mice without TCE
(Table IV and not depicted). Moreover, once the TCE-
bearing mice developed a response, this response never
contained antigen-specific T cells bearing the V  segment
expressed by the TCE (Table IV and not depicted). In fact,
in the case of two mice with V 8 TCE where the cell cul-
ture after the third restimulation contained V 8 cells, these
cells likely belonged to the original TCE, as they did not
stain with gB-8p:Kb tetramers. (mice Sp1.5 and 8197; Ta-
ble IV and its legend).
This leads to two conclusions. First, in the V 8  or
V 10  TCE-bearing mice, the non-TCE cells from the
V 8  or V 10  populations that would normally respond
to gB-8p were either absent or below the numeric threshold
that would allow a productive response. We favor the latter
explanation, based upon the observations that in some ex-
periments we could detect infrequent V 8 or V 10  cells
amongst ex vivo–isolated pMHC  cells (not depicted). This
is consistent with the ability of such cells to expand after
three, but not after one, round of restimulation (Table IV).
Second, compensation for the lost responding V 8  or
V 10  populations in TCE-bearing old mice was either
nonexistent in the case of V 10 TCE or incomplete and
functionally inadequate in the case of most V 8 TCE (Ta-
ble IV). This difference between the V 10 TCE- and V 8
TCE-bearing mice is discussed further below.
As shown in Table IV, the cells that occasionally could
respond to the virus in four out of eight V 8/V 10 TCE-
bearing mice became detectable only after three restimula-
tions in vitro. These cells were functionally less active (lytic
activity  60% lower) than the cells expanded from animals
bearing other TCE or from those not carrying detectable
TCE (Table IV). Experiments are in progress to elucidate
the reasons for this suboptimal response, which could in-
clude the defects in recruitments of the critical signaling
mediators to the sites of TCR–pMHC contact (synapse),
Figure 4. TCE drastically impair the immune response of old mice.
(A) TCE that affect the gB-8p–responding TCRV  families selectively
reduce the number of gB-8p–specific CD8 cells after viral infection. Mice
from Table II were infected i.p. with 106 PFU HSV-1 strain 17 and their
ex vivo response against the immunodominant peptide assessed by gB-8p:Kb
tetramer staining. X   SD are shown for all mice pooled from three ex-
periments. Background tetramer staining of uninfected young and old
controls was undetectable ( 0.1%; not depicted). Differences between the
V 8 and V 10 TCE, the age-matched and “other V ” TCE, and the
age-matched and V 10 TCE groups were not statistically significant. Dif-
ferences between all other groups were statistically significant at P   0.05
or lower. The absolute number of CD8 splenocytes obtained from young
and old animals was superimposable. (B) TCE prevent development of a
CTL response. Standard 51Cr release assay was performed on cells analyzed
in A after 5 d of in vitro restimulation with gB-8p–coated syngeneic spleen
cells (reference 22). Data are shown as mean specific lysis   SD of individ-
ual data from all mice from Table II analyzed in three separate experi-
ments, with background obtained on peptide  targets ( 5%) subtracted.CTL Immunity Impairment by Age-related TCE Expansions 1354
recently identified to be compromised in aged T cells by
Garcia and Miller (38).
Experimentally Induced V 8 TCE Compromises Viral Resis-
tance. Overall, the above data indicate that CD8  TCE can
produce an effect akin to a functional “hole” in the T cell
repertoire, which rather specifically affected the T cell subset
using the same V  segment as the TCE. This, of course,
does not preclude the possibility that these cells could have
other, more general effects on the immune system, as sug-
gested by the recent findings of Zhang et al. and Ortiz-
Suarez et al. (16, 17). However, in our model, such effects
did not prevent a response in those animals bearing TCE af-
fecting TCRV  families not “relevant” for this response.
The germane question, then, is what are the physiologi-
cal consequences of a TCE-related hole in TCR repertoire
in vivo? If the TCE-related holes in the repertoire are det-
rimental to generating certain immune responses, we de-
duced that they could affect antipathogen resistance. If so,
one would expect that mice with TCE that affects the pop-
ulation of HSV-1–responding T cells may have lower resis-
tance against that virus. Unfortunately, due to the com-
bined requirements for TCE screening, animal accrual,
viral titration, and precise age and weight matching, it was
impossible to obtain sufficient numbers of mice with V 8 
and V 10  TCE to perform properly controlled viral resis-
tance experiments, and thus directly test this hypothesis.
However, because V 8 /V 10  TCE were associated
with the functional elimination of those V  families from
the HSV-1–specific response, we used mAb-induced in
vivo elimination of T cells bearing the V 8 family to
mimic the effect of TCE and thus indirectly test the above
hypothesis (Fig. 5 A). Injection of an anti-V 8 mAb re-
sulted in a profound inability to use CTLs bearing the rele-
vant V , as assessed by proliferation and CTL assays in
response to allogeneic spleen cells or to immobilized anti-
TCRV  mAbs, but did not affect the response of T cells
Table IV. CTL Responses to gB-8p after In Vitro Restimulation
Mouse TCE % Lysis first restima % Lysis third restima % gB-8p:Kb  at third restimb % V 8c % V 10
Young control
(H, n   9) — 49 68  97 22 67
Old control
(H, n   9) — 21 51  98 24 52
Old with TCE
Sp3.4 V 8  12 2  97 2 74
Sp2.2 V 8  12 5  97 7 66
Sp1.5 V 8  11 8 5 4 4 0 d 53
8197 V 8  1  10 7 0 d 5
9216 V 8  12 3  96 2 90
8624 V 10  1  1N A N A N A
8615 V 10  1  1N A N A N A
899 V 10  1  1N A N A N A
404 V 41 7 4 3  97 21 64
7197 V 52 4 4 8  97 26 72
6213 V 51 4 3 8  98 16 73
944 V 71 5 4 9  97 18 58
Sp1.4 V 11 27 58  99 19 65
Sp1.1 V 11 25 53  97 29 48
6198 V 13 22 47  97 30 67
Evolution of the in vitro CTL response in old mice bearing TCE. Summary of TCE status, V  use and lytic activity after one and three in vitro
restimulations with the immunodominant gB-8p determinant (E/T ratio of 30:1).
aEx vivo isolated spleen cells were restimulated for one (a) or three (b) weekly cycles using syngeneic irradiated and peptide (gB-8p)–coated spleno-
cytes and lytic activity was tested 5 d after the last restimulation.
bAfter the third restimulation, cells were also analyzed for CD8 T cell specificity using the gB-8p:Kb tetramer.  99% of all cells analyzed were
CD8 . OVA-8p:Kb was used as a control, revealing  0.1% nonspecific staining.
cAfter the third restimulation, cells were stained for the expression of TCRV  segments. Results indicate percent of CD8  cells bearing V 8 or
V 10. There were  0.5% CD4  cells present at this time.
dThese cells failed to stain with the gB-8p:Kb tetramer and were likely the surviving TCE population.
The lysis and V  percentages of control young and old animals without identified TCE are the average of 5 experiments, but representative of 15
(SD was never  5%). Note that no CTL lines were established from mice bearing V 10 plus TCE.
NA, not applicable (as no response was detectable at any time point).Messaoudi et al. 1355
bearing other V s (refer to Materials and Methods). Treated
and control mice were then challenged with a sublethal
dose of HSV-1 (1.5   107 PFU of this particular lot of the
strain 17). Although  15% of the mice receiving the con-
trol antibody succumbed to this dose of virus (2/15), this
number rose to  80% (13/15) amongst the mice treated
with anti-V 8 (Fig. 5 A). Of interest, the surviving  V 8-
treated mice recruited almost exclusively the V 10 
CTLs in response to HSV-1 challenge as detected by tet-
ramer staining (not depicted), similar to the situation in
three times–restimulated cells from V 8 TCE-bearing ani-
mals. This was also found in three out of three moribund
mice analyzed from the same group. In contrast, surviving
mice in the group without depletion recruited both V 8
and V 10.
Finally, to better experimentally mimic the TCE situa-
tion, we experimentally induced TCE in young ATX ani-
mals by depleting V 8 or V 5 T cells in vivo using anti-
bodies and replacing them with transgenic 2C or OT-1
CD8 T cells. A third group of mice was treated with an
isotype mAb control. Both mAbs used caused a complete
depletion of the targeted T cell subset as described in Mate-
rials and Methods. Moreover, the groups represented inter-
nal controls for each other: V 8-depleted animals con-
tained a polyclonal V 5 population and vice versa. After
transgenic T cell transfer, all three groups were challenged
with HSV-1 strain 17 clone syn2 , using a dose that reliably
resulted in 60% survival in adult C57BL/6 mice (6   107
PFU). While 60–67% of the control and the V 5-TCE
(OT-1) groups survived this dose, none of the V 8 TCE
group survived (Fig. 5 B). The results were statistically sig-
nificant, at the level of P   0.03.
Thus, inactivation of T cells expressing a TCRV  family
that participates in a CTL response against HSV-1 reduced
the resistance to that pathogen. Because the presence of
TCE amongst a particular TCRV   T cell subset effec-
tively abolishes the participation of naive cells from that
subset in a productive immune response, it is likely that
TCE have the potential to similarly impair the pathogen
resistance in aged individuals.
Discussion
The above results demonstrate the potential of TCE to
impair new immune responses, suggesting that they con-
tribute to the immune deficiency of the elderly. We docu-
mented that this defect is focused, which would be ex-
pected given that the TCR diversity is heavily reduced
only in the CD8  population bearing the same V  as the
TCE. This strongly suggests that the regulation of TCE
and TCR family homeostasis is separate for CD8 and CD4
subsets, and is consistent with other results indicating that
the two represent separately regulated compartments (31–
35), including the fact that CD8 and CD4 T cells do not
compete with one another in homeostatic proliferation (31,
32) and that in animals deficient in one of these subsets or
in transfer experiments, the other subset does not “fill the
void” (33, 34, 35).
The finding that TCE preferentially affect the immune
responses that normally recruit T cell populations bearing
the same V  family appears somewhat unexpected. How-
ever, the explanation of how TCE preferentially affect
certain immune responses can be found in the numerical
analysis of T cell diversity and frequencies. Analysis by Cas-
rouge et al. (39) estimated that the murine T cell repertoire
contains  6   105 V  sequences, each distributed on
30–50 cells. This allows one to estimate TCE-associated
reduction of antigen-specific precursor diversity and fre-
quency. For example, in the case of mouse Sp3.4 (Table I),
Figure 5. Elimination of one responding TCRV  family significantly
reduces antiviral resistance. (A) 25 mice/group (two experiments) were
treated with experimental (anti-V 8) or isotype-matched control mAbs
(19E12, anti-Thy1.1) and infected with an otherwise sublethal dose of
HSV-1 (1.5   107 PFU/mouse, strain 17). Survival after 100 d is shown
as average percent survival   SD. All morbidity and mortality ensued
within 7–14 d after infection. Survival after 100 d is shown as percent
mean survival   SD. (B) C57BL/6 mice were thymectomized at 5 wk of
age and then depleted either of V 5 or V 8 T cells using a single injec-
tion of mAbs (MR9.4 and F23.1 clones, respectively), or left untreated
(control group). The efficiency of T cell depletion was verified by FCM 2
wk after the antibody injection and immediately before viral challenge (4
mo later). At 5 mo of age, the animals depleted of V 5 T cells received a
transfer of 20   106 OT-1 T cells, and those depleted of V 8 received
20   106 2C T cells. Transfer success was assessed using FCM 24 h later.
The animals were rested for an additional 24 h before viral challenge with
6   107 HSV-I strain 17, clone syn2 . This dose was shown reliably in
our laboratory to kill  40% unmanipulated, 4-mo-old C57BL/7 mice. A
total of 12 animals/group was used. Survival after 100 d is shown as aver-
age percent survival   SD as explained above.CTL Immunity Impairment by Age-related TCE Expansions 1356
a V 8 TCE takes up  71% of the CD8 repertoire. V 8
normally makes up  20.4% of total CD8 T cells, or 0.4–
0.6   105 different sequences (assuming CD8/CD4 ratios
to be between 1:2 and 1:1), each present on 10–50 cells
(39). We know that young and old mice have comparable
numbers of CD8 T cells in secondary lymphoid organs,
with old spleens being larger, but containing lower relative
CD8 T cell numbers. Therefore, a major expansion in one
V  population should reduce representation of T cells be-
longing to other populations across the board. Indeed, our
results show that this is true within the CD8 T cell com-
partment, and the fact that the CD4 compartment remains
mostly unperturbed is irrelevant for the case of TCE affect-
ing class I–restricted responses. In the case of mouse SP3.4,
where the V 8  cells increase  3.5-fold (from 20 to 71%),
it follows (refer to Materials and Methods) that T cells
bearing other V  populations will decrease in representa-
tion by 2.74-fold each, assuming that such reduction occurs
independently of TCR chain sequence. In that case, the
average population of 30–50 cells expressing a gB-8p–reac-
tive V 10 sequence in this mouse would be reduced to
 4–12 cells. Although many T cells bearing gB-8p–reac-
tive V 10 sequences would fail to react to gB-8p due to
TCR-  chain influences, a fraction of them (2–10% ac-
cording to our preliminary data from TCR-  transgenic
mice) would recognize gB-8p:Kb, particularly given the
crucial role of TCR-  chain in recognition of gB-8p:Kb
(40). Thus, 11–18 cells/sequence and several “responding
sequences” or T cell clones (40) would make up for a suffi-
cient number of T cell precursors bearing TCRV 10 to
respond to pathogen challenge.
A very different situation pertains to the CD8  V 8 cells
if the TCE is of the V 8 type. In the mouse Sp3.4 (71% of
the CD8 repertoire), almost the entire V 8 family ( 97%
sequences) is taken up by the TCE. In the CD8 subset, that
leaves  3% of T cells in that family to represent all mem-
ory and naive cells, including those with potential to re-
spond to gB-8p. Simple calculation reveals that the maxi-
mal percentage of diverse V 8 cells (71   3%   2.1%) is
reduced by about tenfold compared with animals without
TCE that contain  20% V 8  cells. Therefore, the repre-
sentation of cells bearing diverse V 8 sequences in mouse
Sp3.4 with a V 8 TCE would drop from 30–50 to 3–5 or
less, with a realistic possibility that none would be specific
for gB-8p (due to TCR-  effects, maintenance of memory
cell in the same pool, etc.). Of note, the difference in di-
versity reduction between the T cells outside the TCE and
those that share the V  family with TCE is even more
drastic in animals with lower absolute expansion levels,
where the TCE still takes  97% of all sequences (i.e., in
mouse Sp2.2, the reduction is  20-fold within V 8, but
only 1.3-fold for all other families). Even if no other mech-
anisms were contributing to the delayed and reduced im-
mune response of the old animals, this reduction in precur-
sor frequency would easily explain the extremely weak and
delayed response of non-TCE clones coexisting in the
same V  family with the TCE. Note that this discussion as-
sumes an even and balanced reduction in all T cells regard-
less of sequence or immunological experience. If, however,
memory cells are selectively maintained in the repertoire of
the aged animals (1, 3, 4, 18, 41) and if one takes into the
account the increased CD8/CD4 ratios described in old
animals (1, 3, 18), then diversity would be expected to un-
dergo even more reduction.
In our experiments, there seemed to be better compensa-
tion for the TCE-related lost of V 8  gB-8p precursors
than for the loss of V 10  T cells. We explain this by differ-
ent participation of CTLs from these populations in the
anti–gB-8p response, and by the unique dependence of this
response in B6 mice upon germline VDJ elements (42).
Thus, if gB-8p–specific V 10 CTL precursors (CTLp) out-
number the V 8 gB-8p–specific CTLp by  3:1 (as sug-
gested by dominant recruitment of CTLs from this T cell
population in young mice), then in V 8 TCE-bearing ani-
mals the V 10 CTLp can belatedly compensate for the
depressed or nonexistent response of gB-8p–specific V 8
CTLp (as their number would remain sufficient for expan-
sion/detection after several stimulations), but in V 10
TCE-bearing animals frequencies of V 8 gB-8p–specific
CTLp would be insufficient to mount a detectable response.
Indeed, in many cases compensation between different T
cell populations after the loss of TCR diversity is incom-
plete or absent (for review see reference 43) and in the spe-
cific case of this HSV-1 response in H-2b mice, it was
shown previously that the absence of germline J 2-D 2
segments knocks the V 10 family from this response, but
that V 8  CD8 T cells only feebly compensate for the loss;
the mobilized response reaches  40% of the response in the
presence of V 10 participation (42). An alternative explana-
tion, that V 10  T cells have higher avidity for the cognate
pMHC than those bearing V 10 , is highly unlikely, as we
failed to detect any such differences using pMHC tetramers
to evaluate the kinetics of TCR–pMHC interaction in
these T cell populations (unpublished data). Most impor-
tantly, it is crucial to note that this compensation, which is
slowed and rendered even less efficient by the intrinsic de-
fects in activation of old T cells, is belated and fails to ensure
responsiveness to the virus in a timely manner.
At the present, we do not understand many of the details
of the age-related dysregulation of peripheral T cell diver-
sity and of the TCE ontogeny, including the reason why a
TCE accumulates in a fashion to initially preferentially di-
lute out the T cells bearing the same family of TCRV 
proteins, while affecting other neighboring T cell popula-
tions bearing different TCRs (V s) to a lesser extent. This,
together with the surprisingly tight control of the represen-
tation of T cell populations bearing different TCRV , sug-
gests that T cell diversity might be under homeostatic con-
trol. Neither the existence nor the mechanistic details of
this control are firmly established at this time. However,
one could speculate that there are two mechanisms to con-
trol peripheral T cell homeostasis: a general homeostatic
mechanism, supported by our current knowledge (44), reg-
ulates total number of T cells in a compartment (likely
based on contact inhibition, TCR–self-pMHC interaction,
and/or general survival/maintenance factors such as IL-15;Messaoudi et al. 1357
reference 15), and another, presently speculative, mecha-
nism, that regulates the relative abundance of T cell subsets
based upon TCR sequence diversity. That second mecha-
nism could operate via a finite number of distinct survival-
mediating ligands, each of which is occupied by CD8 or
CD4 T cells (separate niches) bearing TCRs with different
structural characteristics. This mechanism could operate
based on TCRV  family expression, similar to regulation
mechanisms proposed before (27–29), but still incom-
pletely understood. A distinct ligand/niche would attract
TCRV 8 cells and would provide them with survival sig-
nals based upon TCR binding, perhaps not unlike low
avidity, sub-activation threshold interaction between TCR
and pMHC or MHC-endogenous superantigen. TCE
would originate from T cells that became independent of
the ligand-mediated survival signal (and that thus have sur-
vival advantage over other T cells), but that still effectively
bind the survival-promoting ligand, thus progressively out-
competing other cells bearing the same V  (15). Mean-
while, the constriction of the rest of the TCR repertoire
would occur later, beginning only when a TCE fully occu-
pies the space allocated to the pool of cells bearing the same
TCR structural element and starts to accumulate above this
level. At this point, TCE would act as a “sink” for the gen-
eral maintenance factors, thus competing out other T cells
in a TCR-independent manner (general homeostatic mech-
anism). Alternatively, TCE could differ from other mem-
ory T cell subsets by secreting (and also being resistant
to antiproliferative effects of) IFN-  and possibly IFN- ,
which then inhibits the ability of other, non-TCE cells to
proliferate. This is consistent with the findings of Zhang et
al. (16) that aged non-TCE CD8 T cells respond poorly to
IL-15 due to environmental IFN-I, and with findings of
Ortiz-Suarez and Miller (17) that an actively proliferating
subset of aged CD8  CD28hi T cells secrete high levels of
IFN- . Inasmuch as Ku et al. (15) showed that TCE have
higher CD28 levels than average memory CD8 T cells, the
subset identified by Ortiz-Suarez and Miller (17) would be
likely to contain TCE. All of these cytokines would work
at the general level, as could IL-7, recently implicated in
the maintenance of memory CD8 cells (44).
Although experiments are underway to test the exist-
ence and operation of the hypothetical V -specific mech-
anism, as well as the reliance of this regulation on TCR
specificity (45), exact TCR CDR region sequence and
specificity, and regulatory cytokines, their results would
not affect the major conclusions of this study. Indeed, re-
gardless of mechanistic issues, which are outside the scope
of this study, results presented here suggest that the func-
tional knockout of one TCR family by the age-related
TCE can lead to potentially serious impairment of im-
mune resistance. We conclude that CD8  TCE can clearly
constrict the available CD8  T cell repertoire and are
likely to not only be a consequence of, but also a contrib-
uting factor to, the immunodeficiency of the senescence.
Understanding the harmful effects of these cells on a pro-
ductive immune response should stimulate new strategies
to prevent the onset or eliminate the existing clonal ex-
pansions as means to treat and ameliorate the immunodefi-
ciency of the senescence.
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